Vontobel Holding’s ResMed RMD Stock Holding History

Vontobel Holding’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-900	Closed	-$232K	–	1418
2025 Q2	$232K	Buy	+900	New	+$215K	﹤0.01%	1128

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vontobel Holding's RMD Position: Q2 2026 in Review

Vontobel Holding reduced its ResMed (RMD) stake by 28% in Q2 2026, selling an estimated $306K and leaving 3,864 shares worth $753K. The position accounts for ﹤0.01% of the portfolio, ranked #905.

Vontobel Holding first reported a position in RMD in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.63M in Q2 2023. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Vontobel Holding held 3,864 shares of ResMed worth $753K as of Q2 2026.
Vontobel Holding sold 1,478 ResMed shares in Q2 2026, an estimated $306K.
ResMed made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #905 holding.
Vontobel Holding first reported a position in ResMed in Q4 2020 and has held it in 23 quarters since.
Vontobel Holding's ResMed position peaked at $3.63M in Q2 2023.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.